ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Veerhealth Care Earnings Call: Key Takeaways

Veerhealth Care (ayuVeer) reported FY26 revenue of ₹32.48 Cr and PAT of ₹0.54 Cr. Strategy focuses on 'Local to Global' expansion, USFDA-cleared OTC exports, and backward integration via Veer Plast.

Guidance and delivery
Management target Revenue 23.0% FY26
Highlights
Revenue growth92.5% YoY in FY26.
MarginsTargeting 10% PAT margin for FY26.
Order bookReceived ₹0.74 Cr export order; monthly US shipments targeted.
Demand visibilityStrong; US export orders secured.
Management confidenceHigh; targets ₹35-40 Cr revenue.

Growth

FY26 Revenue grew 92.5% YoY to ₹32.48 Cr; EBITDA reached ₹3.27 Cr; PAT increased to ₹0.54 Cr from ₹0.39 Cr.

Outlook

FY26 revenue guidance of ₹35-40 Cr with 10% PAT. Planning expansion into Russian and US medical device markets.

Risks

Exposure to Indian and international economic volatility, high competition in oral care, and regulatory compliance risks.

Source

Earnings Call filed with BSE, NSE: NIYATILEAS. Summary written with AI assistance from the document.

Read the document ↗

Veerhealth Care Ltd: key numbers

Share price
₹52.50
Market cap
₹105.0 Cr
Revenue (annual)
₹32.48 Cr
Net profit (annual)
₹0.54 Cr
P/E (TTM)
68.6×Sector 43.8×
Promoter holding
31.88%-0.03% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Veerhealth Care Ltd

All →